Dening, Yanina
Straßl, Theresa
Ruf, Viktoria
Dirscherl, Petra
Chovsepian, Alexandra
Stievenard, Alicia
Khairnar, Amit
Schmidt, Felix
Giesert, Florian
Herms, Jochen
Levin, Johannes
Dieterich, Marianne
Falkai, Peter
Weisenhorn, Daniela Vogt
Wurst, Wolfgang
Giese, Armin
Pan-Montojo, Francisco
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198, 390857198)
FP7 People: Marie-Curie Actions (291782)
Universitätsklinik München
Article History
Received: 15 June 2022
Accepted: 5 December 2022
First Online: 19 December 2022
Competing interests
: Johannes Levin reports speaker fees from Bayer Vital, Biogen and Roche, consulting fees from Axon Neuroscience and Biogen, author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers, non-financial support from Abbvie and compensation for duty as part-time CMO from MODAG, outside the submitted work. Francisco Pan-Montojo reports consulting fees as external CSO from NEUREVO GmbH, also outside the submitted work. All other authors declare no conflict of interest.